MARAGANORE JOHN sold COAG
May 4, 2026 · Form 4 insider transaction
MARAGANORE JOHN sold 817 shares of Hemab Therapeutics Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
817
Price
$0.00
Total value
N/A
InsiderMARAGANORE JOHN
RoleDirector
SecuritySeries B Preferred Stock
Transaction codeC: Conversion of a derivative
Transaction dateMay 4, 2026
Filing dateMay 4, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The warrant was granted on January 29, 2026. The shares underlying the warrant vest over three years in equal monthly installments from January 1, 2026 through January 1, 2029.; Each share of Series B Preferred Stock and Series C Preferred Stock converted into 22 shares of common stock without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.